Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE).
Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O'Neill FA, Osborn D, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team. Crawford MJ, et al. Among authors: clayton k. Health Technol Assess. 2012;16(8):iii-iv, 1-76. doi: 10.3310/hta16080. Health Technol Assess. 2012. PMID: 22364962 Free article. Clinical Trial.
The MATISSE study: a randomised trial of group art therapy for people with schizophrenia.
Crawford MJ, Killaspy H, Kalaitzaki E, Barrett B, Byford S, Patterson S, Soteriou T, O'Neill FA, Clayton K, Maratos A, Barnes TR, Osborn D, Johnson T, King M, Tyrer P, Waller D. Crawford MJ, et al. Among authors: clayton k. BMC Psychiatry. 2010 Aug 27;10:65. doi: 10.1186/1471-244X-10-65. BMC Psychiatry. 2010. PMID: 20799930 Free PMC article. Clinical Trial.
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial.
Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O'Neill FA, Osborn DP, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team. Crawford MJ, et al. Among authors: clayton k. BMJ. 2012 Feb 28;344:e846. doi: 10.1136/bmj.e846. BMJ. 2012. PMID: 22374932 Free PMC article. Clinical Trial.
Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS. Huang YH, et al. Among authors: clayton kl. Nature. 2024 Feb;626(8001):E19. doi: 10.1038/s41586-024-07164-y. Nature. 2024. PMID: 38336833 No abstract available.
Harnessing immune cells to eliminate HIV reservoirs.
Grasberger P, Sondrini AR, Clayton KL. Grasberger P, et al. Among authors: clayton kl. Curr Opin HIV AIDS. 2024 Mar 1;19(2):62-68. doi: 10.1097/COH.0000000000000840. Epub 2024 Jan 2. Curr Opin HIV AIDS. 2024. PMID: 38167784 Review.
On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine.
Dahal S, Clayton K, Cabral T, Cheng R, Jahanshahi S, Ahmed C, Koirala A, Villasmil Ocando A, Malty R, Been T, Hernandez J, Mangos M, Shen D, Babu M, Calarco J, Chabot B, Attisano L, Houry WA, Cochrane A. Dahal S, et al. Among authors: clayton k. J Virol. 2023 Oct 31;97(10):e0039623. doi: 10.1128/jvi.00396-23. Epub 2023 Sep 14. J Virol. 2023. PMID: 37706687 Free PMC article.
Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting.
Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A. Lilie T, et al. Among authors: clayton k. medRxiv [Preprint]. 2023 Jun 3:2023.05.26.23290576. doi: 10.1101/2023.05.26.23290576. medRxiv. 2023. PMID: 37398278 Free PMC article. Preprint.
152 results